These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4695598)

  • 21. [Evaluation of fluphenazine use since establishment of a psychiatric section].
    Roger BM
    Ann Med Psychol (Paris); 1972 Apr; 1(4):550-5. PubMed ID: 4342755
    [No Abstract]   [Full Text] [Related]  

  • 22. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled study of fluspirilene in chronic schizophrenia.
    Villeneuve A; Dogan K; Lachance R; Proulx C
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):819-27. PubMed ID: 4994687
    [No Abstract]   [Full Text] [Related]  

  • 24. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR; Levine J; Severe JB
    Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa; Vovina EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):920-4. PubMed ID: 5050052
    [No Abstract]   [Full Text] [Related]  

  • 27. [Delayed action neuroleptic agents].
    Rainaut J
    Evol Psychiatr (Paris); 1970; 35(4):897-955. PubMed ID: 5503625
    [No Abstract]   [Full Text] [Related]  

  • 28. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with depot neuroleptic drugs in psychiatry].
    Heinrich K
    Evol Psychiatr (Paris); 1970; 35(14):953-5. PubMed ID: 5508726
    [No Abstract]   [Full Text] [Related]  

  • 30. Maintenance treatment with long-acting neuroleptic drugs in persons with disturbances of social behavior and drug dependence.
    Drtil M; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1973 May; 15(2):87. PubMed ID: 4752679
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 32. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personal experience with prolonged-action fluphenazine].
    Król K; Krystof J
    Psychiatr Pol; 1974; 8(2):149-55. PubMed ID: 4830322
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fluphenazine in low and high doses in the therapy of chronic schizophrenia. (Comparative study of 40 cases)].
    Vinci M; Livi Bacci R
    Osp Psichiatr; 1969; 37(3):371-404. PubMed ID: 5383005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience with a new depot neuroleptic].
    Christiani K
    Med Klin; 1969 Sep; 64(39):1761-2. PubMed ID: 5346114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].
    Scherrer P; Quiniou-Vidalenc
    Ann Med Psychol (Paris); 1976 Nov; 2(4):642-56. PubMed ID: 1020862
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pimozide compared with fluphenazine in schizophrenia.
    Kenway AK; Masheter HC
    Br J Clin Pract; 1971 Feb; 25(2):69-72. PubMed ID: 4927983
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.